NDC 0378-5011-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-5011
- Requested NDC
- 0378-5011-05
- Package NDCs from labels
- 0378-5011-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-5011-01 | EA - Each | 0378-5011 | 3107fb9d-f042-44f4-ab48-ed0b2c768bc4 | 1 | 2012-07-24 |
| 0378-5011-05 | EA - Each | 0378-5011 | a557fbda-923a-4dff-8118-098742e11930 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 257cee60-b68f-4c2b-b57d-8e4d73d17e09 | 2026-10-30 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 48fbc535-a33a-45ee-85ff-9d1ec9b31d9c | 2026-10-30 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sirolimus | SIROLIMUS | Mylan Pharmaceuticals Inc. | 384cb547-55a4-47fc-a0a6-054c18a51b84 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Midodrine Hydrochloride | MIDODRINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 32fad00b-7e7b-4d35-9e8b-fdc979fdb88e | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glatiramer Acetate | GLATIRAMER ACETATE | Mylan Pharmaceuticals Inc. | f38b5606-d2d7-44ec-912f-46882aa2fa7b | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glatiramer Acetate | GLATIRAMER | Mylan Pharmaceuticals Inc. | 456a34c7-8511-4000-99a7-ad8f8de6d35e | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Prednisone | PREDNISONE | Mylan Pharmaceuticals Inc. | fec09050-5ac2-451b-a2b9-5a21b2def212 | 2026-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Metformin Hydrochloride | METFORMIN | Mylan Pharmaceuticals Inc. | 7e41818c-60e9-4bcf-9586-7bb8d33d5e89 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Clonidine | CLONIDINE | Mylan Pharmaceuticals Inc. | 7adfc439-e6d0-4593-87dd-0eef36d33c6d | 2026-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Imatinib Mesylate | IMATINIB | Mylan Pharmaceuticals Inc. | a1787fad-3612-43e1-98fa-ce62361e0b3c | 2026-09-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Valsartan | VALSARTAN | Mylan Pharmaceuticals Inc. | 73e01dc6-7dd4-421a-a4f6-137e75f69f9a | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Diazepam | DIAZEPAM | Mylan Pharmaceuticals Inc. | c397a9da-862f-4f3f-8109-7d21691de53a | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Diclofenac sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Mylan Pharmaceuticals Inc. | a7701e8c-4e16-4165-8b83-de2c08d5ded3 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Mylan Pharmaceuticals Inc. | 1d2cd01c-05e7-44cf-a71d-0f474e826b7e | 2026-08-26 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| misoprostol | MISOPROSTOL | Mylan Pharmaceuticals Inc. | c4fe14fb-0a43-4c31-9cd6-29eb0d156705 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Saxagliptin and Metformin | SAXAGLIPTIN AND METFORMIN | Mylan Pharmaceuticals Inc. | cbf8677c-cafe-48bc-8844-0cc6547886bd | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Atovaquone and Proguanil Hydrochloride | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 57d74d71-8cf8-4b10-9420-22954fae623c | 2026-08-20 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Amnesteem | ISOTRETINOIN | Mylan Pharmaceuticals Inc. | b2cb63c9-f825-4991-9a2c-6260f1bbcc2c | 2026-08-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 56b3f4c2-52af-4947-b225-6808ae9f26f5 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.